CYB5R3: A Drug Target / Disease Biomarker (G1727)

Target Name: CYB5R3

NCBI ID: G1727

CYB5R3

CYB5R3: A Drug Target / Disease Biomarker

CYB5R3, also known as SIRT3, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for a variety of diseases. Its unique structure and function have made it an intriguing target for researchers to study.

CYB5R3 is a small non-coding RNA molecule that is approximately 200 nucleotides long. It is expressed in most tissues and cells of the body and is involved in a variety of cellular processes. One of its main functions is to regulate the expression of genes. It does this by binding to specific DNA sequences and helping to ensure that the RNA polymerase machinery is able to accurately read the genetic information in the DNA.

One of the things that makes CYB5R3 so interesting as a potential drug target is its ability to interact with a variety of different molecules. This makes it a promising target for drugs that are designed to modulate its activity. For example, scientists have found that CYB5R3 can interact with small molecules such as drugs that are used to treat a variety of diseases, including cancer, cardiovascular disease, and neurodegenerative disorders.

Another reason why CYB5R3 is an attractive drug target is its unique structure. Unlike many other RNA molecules, CYB5R3 has a specific, repeating pattern of nitrogenous bases. This pattern is called a motif and is a common feature of many RNA molecules. However, CYB5R3 has a unique motif that is specific to it. This has made it an attractive target for researchers because it allows them to study the molecular mechanisms that are involved in its function.

In addition to its unique structure and its ability to interact with a variety of different molecules, CYB5R3 has also been shown to have a variety of different functions in the body. For example, it has been shown to play a role in the regulation of gene expression in the immune system, the balance of protein synthesis and degradation in the cell, and the regulation of cell death.

Overall, CYB5R3 is a fascinating molecule that has a lot of potential as a drug target. Its unique structure and function have made it an attractive target for researchers who are looking for new and innovative treatments for a variety of diseases. As more research is conducted on CYB5R3, it is likely to become even more important as a potential drug target and biomarker.

Protein Name: Cytochrome B5 Reductase 3

Functions: Catalyzes the reduction of two molecules of cytochrome b5 using NADH as the electron donor

The "CYB5R3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CYB5R3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets